Local surgical, ablative, and radiation treatment of metastases

Robert D. Timmerman, Costas S. Bizekis, Harvey I. Pass, Yuman Fong, Damian E. Dupuy, Laura A. Dawson, David Lu

Research output: Contribution to journalArticle

130 Citations (Scopus)

Abstract

Because local therapies directed toward a specific tumor mass are known to be effective for treating early-stage cancers, it should be no surprise that there has been considerable historical experience using local therapies for metastatic disease. In more recent years, increasing interest in the use of local therapy for metastases likely has arisen from improvements in systemic therapy. In the absence of effective systemic therapies, such local treatments were often considered futile given both the difficulty in eliminating all sites of identifiable metastatic disease as well as realities regarding the rapid natural history of uncontrolled tumor dissemination. However, with a higher likelihood of patients surviving longer after effective systemic therapy, even if not cured, the goal of the eradication of residual metastases via potent local therapies can be rationalized. However, this rationalization should be evidence-based so as to avoid harming patients for no established benefit. Although surgical metastectomy remains the most common and first-line standard among local therapies, nonsurgical alternatives, including thermal ablation and stereotactic body radiotherapy, have become increasingly popular because they are generally less invasive than surgery and have demonstrated considerable promise in eradicating macroscopic tumor. Rather than eliminating the need for local therapies, improvements in systemic therapies appear to be increasing the prudent utilization of modern local therapies in patients presenting with more advanced cancer.

Original languageEnglish (US)
Pages (from-to)145-170
Number of pages26
JournalCA Cancer Journal for Clinicians
Volume59
Issue number3
DOIs
StatePublished - May 2009

Fingerprint

Radiation
Neoplasm Metastasis
Therapeutics
Neoplasms
Radiosurgery
Complementary Therapies
Hot Temperature

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Timmerman, R. D., Bizekis, C. S., Pass, H. I., Fong, Y., Dupuy, D. E., Dawson, L. A., & Lu, D. (2009). Local surgical, ablative, and radiation treatment of metastases. CA Cancer Journal for Clinicians, 59(3), 145-170. https://doi.org/10.3322/caac.20013

Local surgical, ablative, and radiation treatment of metastases. / Timmerman, Robert D.; Bizekis, Costas S.; Pass, Harvey I.; Fong, Yuman; Dupuy, Damian E.; Dawson, Laura A.; Lu, David.

In: CA Cancer Journal for Clinicians, Vol. 59, No. 3, 05.2009, p. 145-170.

Research output: Contribution to journalArticle

Timmerman, RD, Bizekis, CS, Pass, HI, Fong, Y, Dupuy, DE, Dawson, LA & Lu, D 2009, 'Local surgical, ablative, and radiation treatment of metastases', CA Cancer Journal for Clinicians, vol. 59, no. 3, pp. 145-170. https://doi.org/10.3322/caac.20013
Timmerman, Robert D. ; Bizekis, Costas S. ; Pass, Harvey I. ; Fong, Yuman ; Dupuy, Damian E. ; Dawson, Laura A. ; Lu, David. / Local surgical, ablative, and radiation treatment of metastases. In: CA Cancer Journal for Clinicians. 2009 ; Vol. 59, No. 3. pp. 145-170.
@article{1046081adb3543bf9072d60ce2b937ee,
title = "Local surgical, ablative, and radiation treatment of metastases",
abstract = "Because local therapies directed toward a specific tumor mass are known to be effective for treating early-stage cancers, it should be no surprise that there has been considerable historical experience using local therapies for metastatic disease. In more recent years, increasing interest in the use of local therapy for metastases likely has arisen from improvements in systemic therapy. In the absence of effective systemic therapies, such local treatments were often considered futile given both the difficulty in eliminating all sites of identifiable metastatic disease as well as realities regarding the rapid natural history of uncontrolled tumor dissemination. However, with a higher likelihood of patients surviving longer after effective systemic therapy, even if not cured, the goal of the eradication of residual metastases via potent local therapies can be rationalized. However, this rationalization should be evidence-based so as to avoid harming patients for no established benefit. Although surgical metastectomy remains the most common and first-line standard among local therapies, nonsurgical alternatives, including thermal ablation and stereotactic body radiotherapy, have become increasingly popular because they are generally less invasive than surgery and have demonstrated considerable promise in eradicating macroscopic tumor. Rather than eliminating the need for local therapies, improvements in systemic therapies appear to be increasing the prudent utilization of modern local therapies in patients presenting with more advanced cancer.",
author = "Timmerman, {Robert D.} and Bizekis, {Costas S.} and Pass, {Harvey I.} and Yuman Fong and Dupuy, {Damian E.} and Dawson, {Laura A.} and David Lu",
year = "2009",
month = "5",
doi = "10.3322/caac.20013",
language = "English (US)",
volume = "59",
pages = "145--170",
journal = "CA Cancer Journal for Clinicians",
issn = "0007-9235",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Local surgical, ablative, and radiation treatment of metastases

AU - Timmerman, Robert D.

AU - Bizekis, Costas S.

AU - Pass, Harvey I.

AU - Fong, Yuman

AU - Dupuy, Damian E.

AU - Dawson, Laura A.

AU - Lu, David

PY - 2009/5

Y1 - 2009/5

N2 - Because local therapies directed toward a specific tumor mass are known to be effective for treating early-stage cancers, it should be no surprise that there has been considerable historical experience using local therapies for metastatic disease. In more recent years, increasing interest in the use of local therapy for metastases likely has arisen from improvements in systemic therapy. In the absence of effective systemic therapies, such local treatments were often considered futile given both the difficulty in eliminating all sites of identifiable metastatic disease as well as realities regarding the rapid natural history of uncontrolled tumor dissemination. However, with a higher likelihood of patients surviving longer after effective systemic therapy, even if not cured, the goal of the eradication of residual metastases via potent local therapies can be rationalized. However, this rationalization should be evidence-based so as to avoid harming patients for no established benefit. Although surgical metastectomy remains the most common and first-line standard among local therapies, nonsurgical alternatives, including thermal ablation and stereotactic body radiotherapy, have become increasingly popular because they are generally less invasive than surgery and have demonstrated considerable promise in eradicating macroscopic tumor. Rather than eliminating the need for local therapies, improvements in systemic therapies appear to be increasing the prudent utilization of modern local therapies in patients presenting with more advanced cancer.

AB - Because local therapies directed toward a specific tumor mass are known to be effective for treating early-stage cancers, it should be no surprise that there has been considerable historical experience using local therapies for metastatic disease. In more recent years, increasing interest in the use of local therapy for metastases likely has arisen from improvements in systemic therapy. In the absence of effective systemic therapies, such local treatments were often considered futile given both the difficulty in eliminating all sites of identifiable metastatic disease as well as realities regarding the rapid natural history of uncontrolled tumor dissemination. However, with a higher likelihood of patients surviving longer after effective systemic therapy, even if not cured, the goal of the eradication of residual metastases via potent local therapies can be rationalized. However, this rationalization should be evidence-based so as to avoid harming patients for no established benefit. Although surgical metastectomy remains the most common and first-line standard among local therapies, nonsurgical alternatives, including thermal ablation and stereotactic body radiotherapy, have become increasingly popular because they are generally less invasive than surgery and have demonstrated considerable promise in eradicating macroscopic tumor. Rather than eliminating the need for local therapies, improvements in systemic therapies appear to be increasing the prudent utilization of modern local therapies in patients presenting with more advanced cancer.

UR - http://www.scopus.com/inward/record.url?scp=65649120797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649120797&partnerID=8YFLogxK

U2 - 10.3322/caac.20013

DO - 10.3322/caac.20013

M3 - Article

C2 - 19364702

AN - SCOPUS:65649120797

VL - 59

SP - 145

EP - 170

JO - CA Cancer Journal for Clinicians

JF - CA Cancer Journal for Clinicians

SN - 0007-9235

IS - 3

ER -